NKTR - Pinduoduo XPeng Trip.com among premarket losers' pack
Nektar Therapeutics (NASDAQ:NKTR) -49% after phase 3 trial in skin cancer with Bristol Myers fails. Electric Last Mile Solutions (NASDAQ:ELMS) -31%. Marine Petroleum (NASDAQ:MARPS) -23%. Enservco (NYSE:ENSV) -20%. Hycroft Mining Holding (NASDAQ:HYMC) -19%. Excellon Resources (NYSE:EXN) -17%. Houston American Energy (NYSE:HUSA) -13%. Imperial Petroleum (NASDAQ:IMPP) -14%. Kaival Brands Innovations (NASDAQ:KAVL) -11%. Futu Holdings (NASDAQ:FUTU) -11%. Trip.com Group (NASDAQ:TCOM) -10%. Clearside Biomedical (NASDAQ:CLSD) -10%. Huazhu Group (NASDAQ:HTHT) -10%. Zhihu (NYSE:ZH) -10% on Q4 earnings release. Cloopen Group Holding (NYSE:RAAS) -10%. Digital Brands Group (NASDAQ:DBGI) -10%. Weibo (NASDAQ:WB) -10%. GDS Holdings (NASDAQ:GDS) -10%. KE Holdings (NYSE:BEKE) -9%. Bilibili (NASDAQ:BILI) -9%. New Concept Energy (NYSE:GBR) -9%. XPeng (NYSE:XPEV) -9%. Pinduoduo (NASDAQ:PDD) -9%. Gran Tierra Energy (NYSE:GTE) -9%. Indonesia Energy Corporation (NYSE:INDO) -9%.
For further details see:
Pinduoduo, XPeng, Trip.com among premarket losers' pack